LBA31 High- vs low-dose pre-operative ipilimumab and nivolumab in locoregionally advanced urothelial cancer (NABUCCO cohort 2)
Year: 2021
Type: conference-abstract
Source: Annals of Oncology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: urothelial carcinoma, ipilimumab, nivolumab, neoadjuvant immunotherapy, cisplatin-ineligible patients, dose comparison, pathological complete response, immune-related adverse events, radical cystectomy, immune checkpoint inhibitors, treatment toxicity, surgical resection timing, progression-free survival
Open Access status: bronze
OpenAlex ID: W3202811014
